Juan Pablo Stefanolo
Overview
Explore the profile of Juan Pablo Stefanolo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
135
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Piskorz M, Stefanolo J, Ibanez A, Eugenia H, Bravo Velez G, Tevez A, et al.
J Clin Gastroenterol
. 2025 Jan;
PMID: 39761161
Background: Irritable bowel syndrome (IBS) is influenced by various factors, including socioemotional stressors. The COVID-19 lockdown created a unique environment characterized by reduced social interactions, potentially impacting IBS symptoms. Aim:...
2.
Carias Dominguez A, de Jesus Rosa Salazar D, Stefanolo J, Cruz Serrano M, Casas I, Zuluaga Pena J
Probiotics Antimicrob Proteins
. 2024 Sep;
17(1):440-449.
PMID: 39235661
Dysbiosis is a clinical condition marked by altered gut microbiota resulting from external and internal host factors. It is strongly associated with gastrointestinal and extraintestinal alterations, so its symptomatology is...
3.
Rahmani S, Galipeau H, Clarizio A, Wang X, Hann A, Rueda G, et al.
Gastroenterology
. 2024 Aug;
167(6):1113-1128.
PMID: 39128638
Background & Aims: Intestinal epithelial cell (IEC) damage is a hallmark of celiac disease (CeD); however, its role in gluten-dependent T-cell activation is unknown. We investigated IEC-gluten-T-cell interactions in organoid...
4.
Stefanolo J, Segura V, Grizzuti M, Heredia A, Comino I, Costa A, et al.
World J Gastroenterol
. 2024 Apr;
30(11):1545-1555.
PMID: 38617446
Background: The gluten-free diet (GFD) has limitations, and there is intense research in the development of adjuvant therapies. Aim: To examine the effects of orally administered prolyl endopeptidase protease (AN-PEP)...
5.
Elli L, Leffler D, Cellier C, Lebwohl B, Ciacci C, Schumann M, et al.
Nat Rev Gastroenterol Hepatol
. 2023 Dec;
21(3):198-215.
PMID: 38110546
Coeliac disease (CeD) is an immunological disease triggered by the consumption of gluten contained in food in individuals with a genetic predisposition. Diagnosis is based on the presence of small...
6.
Stefanolo J, Zingone F, Gizzi C, Marsilio I, Espinet M, Smecuol E, et al.
World J Gastroenterol
. 2022 Dec;
28(43):6157-6167.
PMID: 36483156
Background: Gastroduodenal endoscopy and biopsy following positive specific serology is considered the gold standard to diagnose celiac disease (CeD) in adults. Whether upper endoscopy helps detect comorbid conditions is unknown....
7.
Molino S, Pisarevsky A, Badu S, Wu Q, Lopez Mingorance F, Vega P, et al.
J Funct Foods
. 2022 Dec;
99:105356.
PMID: 36467850
The clinical study aim was to investigate whether a tannin-based dietary supplementation could improve the efficacy of standard-of-care treatment of hospitalized COVID-19 patients by restoring gut microbiota function. Adverse events...
8.
Seiler C, Kiflen M, Stefanolo J, Bai J, Bercik P, Kelly C, et al.
Am J Gastroenterol
. 2021 Jul;
116(9):1968.
PMID: 34240715
No abstract available.
9.
Molino S, Pisarevsky A, Lopez Mingorance F, Vega P, Stefanolo J, Repetti J, et al.
Trials
. 2021 Apr;
22(1):310.
PMID: 33910614
Objectives: This research aims to study the efficacy of tannins co-supplementation on disease duration, severity and clinical symptoms, microbiota composition and inflammatory mediators in SARS-CoV2 patients. Trial Design: This is...
10.
Zhen J, Stefanolo J, Temprano M, Seiler C, Caminero A, de-Madaria E, et al.
World J Gastroenterol
. 2021 Apr;
27(12):1213-1225.
PMID: 33828395
Background: We recently demonstrated that the odds of contracting coronavirus disease 2019 (COVID-19) in patients with celiac disease (CeD) is similar to that of the general population. However, how patients...